Rebecca C Arend (Rebecca Arend)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

Journal of tissue engineering

Cancer medicine

University of Alabama at Birmingham

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alabama at Birmingham Jul 01 2015

United States

Assistant Professor :: OB/GYN

Publications

Laura Moulton Chambers, Paulina Haight, Julia Chalif, Yogita Mehra, Daniel J Spakowicz, Floor J Backes, Casey M Cosgrove, David M O'Malley, Roberto Vargas, Bradley R Corr, Victoria L Bae-Jump, Rebecca C Arend
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-Oncology Research. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Laura Moulton Chambers, Paulina Haight, Julia Chalif, Yogita Mehra, Daniel J Spakowicz, Floor J Backes, Casey M Cosgrove, David M O'Malley, Roberto Vargas, Bradley R Corr, Victoria L Bae-Jump, Rebecca C Arend
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Laura Moulton Chambers, Paulina Haight, Julia Chalif, Yogita Mehra, Daniel J Spakowicz, Floor J Backes, Casey M Cosgrove, David M O'Malley, Roberto Vargas, Bradley R Corr, Victoria L Bae-Jump, Rebecca C Arend
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Alex Seok Choi, Laura M Jenkins, Wade Barton, Asha Kumari, Carly L Lancaster, Calen Raulerson, Hao Ji, Diego Altomare, Mark D Starr, Regina Whitaker, Rebecca Phaeton, Rebecca C Arend, Michael S Shtutman, Andrew B Nixon, Nadine Hempel, Nam Y Lee, Karthikeyan Mythreye
Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling. bioRxiv : the preprint server for biology (2023)
Mingyong Liu, Dmytro Starenki, Christopher D Scharer, Aaron Silva-Sanchez, Patrick A Molina, Jennifer S Pollock, Sara J Cooper, Rebecca C Arend, Alexander F Rosenberg, Troy D Randall, Selene Meza-Perez
Circulating Tregs Accumulate in Omental Tumors and Acquire Adipose-Resident Features. Cancer immunology research 10 (5) (2022)
Rebecca C Arend, Carly Bess Scalise, Emily R Gordon, Allison M Davis, McKenzie E Foxall, Bobbi E Johnston, David K Crossman, Sara J Cooper
Metabolic Alterations and WNT Signaling Impact Immune Response in HGSOC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Rebecca C Arend, David M O'Malley, Susana Banerjee, Kimmie McLaurin, Richard Davidson, Gráinne H Long
Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data. Advances in therapy (2021)
Nidhi Goel, McKenzie E Foxall, Carly Bess Scalise, Jaclyn A Wall, Rebecca C Arend
Strategies in Overcoming Homologous Recombination Proficiency and PARP Inhibitor Resistance. Molecular cancer therapeutics 20 (9) (2021)
Alba Martinez, Molly S Buckley, Carly B Scalise, Dezhi Wang, Ashwini A Katre, Michael J Birrer, Joel L Berry, Rebecca C Arend
Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology. Journal of tissue engineering 12 (2021)
Brandon M Roane, Selene Meza-Perez, Ashwini A Katre, Whitney N Goldsberry, Troy D Randall, Lyse A Norian, Michael J Birrer, Rebecca C Arend
Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma. Molecular cancer therapeutics 20 (3) (2020)
Tyler R McCaw, Nidhi Goel, Dewey J Brooke, Ashwini A Katre, Angelina I Londoño, Haller J Smith, Troy D Randall, Rebecca C Arend
Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer. Cancer medicine 10 (2) (2020)
Julia A Beaver, Robert L Coleman, Rebecca C Arend, Deborah K Armstrong, Sanjeeve Bala, Gordon B Mills, Anil K Sood, Thomas J Herzog
Advancing Drug Development in Gynecologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (16) (2019)

Rebecca C Arend.css-eqlu8i{font-size:small;padding-left:4px;} (Rebecca Arend)

Publication Activity (10 Years)

Top Topics

Top Venues

Rebecca C Arend (Rebecca Arend)